Globela Pharma Private Limited

Globela Pharma Private Limited - pharma in Surat, Gujarat, India. FY 2026 financials and compliance.
CIN U24230GJ2006PTC047699 Incorporated 08 February 2006 ROC Ahmedabad HQ Surat, Gujarat, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹295.59 Cr
▲ 13.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹58 Cr
Registered with MCA
Paid-up capital
₹56.92 Cr
Issued & subscribed
Open charges
₹168.62 Cr
Satisfied ₹16 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
150
Latest available

About Globela Pharma Private Limited

Data last updated: 11 December 2025

Globela Pharma Private Limited is a private limited company based in Surat, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 08 February 2006, the company has been in operation for over 20 years.

Registered with ROC Ahmedabad under CIN U24230GJ2006PTC047699.

Capital: an authorised share capital of ₹58 Cr and a paid-up capital of ₹56.92 Cr. It is led by directors including Mayur Anand Sirdesai and Pietro Ermanno Stefanutti.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Plot No. 357 – 358 Road No. 3 Gidc Sachin, Surat, Gujarat, India – 394230.

As per the financials filed for FY 2025, the company reported a revenue of ₹295.59 Cr, a growth of 13% compared to the previous year.

The company has a workforce of approximately 150 employees as per the latest available data. Its group structure includes 2 subsidiaries.

The company is associated with 1 brand - Globela Pharma. As per MCA filings, the company has open charges of ₹168.62 Cr and satisfied charges of ₹16 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website globelapharma.com.

Company Details of Globela Pharma Private Limited
CIN U24230GJ2006PTC047699
Registration Number 047699
Incorporation Date 08 February 2006
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Plot No. 357 – 358 Road No. 3 Gidc Sachin, Surat, Gujarat, India – 394230
  • Industry
    Pharma, Drug Formulation & Development
Company report
Globela Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Globela Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Globela Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Globela Pharma Private Limited

Globela Pharma Private Limited operates one associated brand: Globela Pharma. These brands represent Globela Pharma Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Finished formulations like tablets, capsules, syrups, and injectables are manufactured. globelapharma.com

Competitors & Alternatives of Globela Pharma Private Limited

Brands and companies operating in the same space as Globela Pharma Private Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.

Competitor Description Location Founded
Jubilant Life Sciences Jubilant Life Sciences Company offering a suite of R&D and manufacturing services for small molecules and generics Noida, India, India 1978
Akums Akums CDMO focusing on spectrum of dosage forms and therapeutic segments Delhi, India, India 2004
Nectar Lifesciences Nectar Lifesciences Cephalosporin APIs and generic formulations are manufactured. Chandigarh, India, India 1995
Windlas Windlas Biopharma regulatory affairs, quality control, and strategy services are provided. Gurugram, India, India 2001
Unither Unither Contract development and manufacturing organization for proprietary and generic drugs Paris, France, France 1993
Recipharm Recipharm Pharmaceutical development and manufacturing services are offered contractually. Jordbro, Sweden, Sweden 1995
CoreRx CoreRx CDMO with a focus on early phase drug product development Clearwater, United States, United States 2006
MedPharm MedPharm Topical and inhaled drug delivery formulations are developed and manufactured. Guildford, United Kingdom, United Kingdom 1998

Business Activity of Globela Pharma Private Limited

Globela Pharma Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Globela Pharma Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Globela Pharma Private Limited

Globela Pharma Private Limited is audited by MSKA & Associates for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
MSKA & Associates Locked Locked Locked
Premium access

Complete auditor history for Globela Pharma Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Globela Pharma Private Limited

Globela Pharma Private Limited is currently managed by 5 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Mayur Anand Sirdesai Director 23 Sep 2021 4 Years 10 Months Current
Pietro Ermanno Stefanutti Director 13 Jan 2022 4 Years 6 Months Current
Bhanubhai Shambhubhai Vaghashia Managing Director 08 Feb 2006 20 Years 5 Months Current
Priyank Vaghashia Director 23 Sep 2021 4 Years 10 Months Current
Urmilaben Bhanubhai Vaghasiya Director 25 Oct 2010 15 Years 9 Months Current

Financials of Globela Pharma Private Limited FY 2024 filings available

Globela Pharma Private Limited reported revenue of ₹295.59 Cr (up 13.00% YoY) for FY 2025.

Revenue · FY 2025
₹295.59 Cr ▲ 13.00%
Premium access

Ten-year financial statements for Globela Pharma Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Globela Pharma Private Limited

Premium access

Shareholding and ownership data for Globela Pharma Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Group Structure of Globela Pharma Private Limited

Globela Pharma Private Limited has 2 subsidiary companies. This group structure data is as of FY 2024. The corporate group structure reflects Globela Pharma Private Limited's business expansion strategy and organizational complexity.

2
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Globela Industries Private Limited U24304GJ2020PTC116892 Locked
Globela Laboratories Private Limited U24304GJ2022PTC129637 Locked

Showing major subsidiaries. Total: 2.

Charges & Borrowings of Globela Pharma Private Limited

Open charges
₹168.62 Cr
Satisfied charges
₹16 Cr
Breakdown by lending institutions
Axis Bank Limited₹161.27 Cr
Sidbi₹7.35 Cr
Latest charge details
DateLenderAmountStatus
05 Aug 2024 Sidbi ₹7.35 Cr Open
06 May 2022 Axis Bank Limited ₹22.06 Cr Open
25 Mar 2022 Axis Bank Limited ₹54.47 Cr Open
28 Mar 2017 Axis Bank Limited ₹42.37 Cr Open
29 Nov 2016 Axis Bank Limited ₹42.37 Cr Open

Total charge records: 10 View all charges

Employees and EPFO Compliance at Globela Pharma Private Limited

Globela Pharma Private Limited has a workforce of 150 employees as of Sep 23, 2025.

Employee count
150
Active EPFO establishments
1
Employee growth
4.17%
Premium access

Employee and EPFO history for Globela Pharma Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Globela Pharma Private Limited

Premium access

GST registrations and filing compliance for Globela Pharma Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Globela Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Globela Pharma Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Globela Pharma Private Limited

Premium access

MSME payment history for Globela Pharma Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Globela Pharma Private Limited

Premium access

Corporate group structure for Globela Pharma Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Globela Pharma Private Limited

Premium access

MCA filings and documents for Globela Pharma Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Globela Pharma Private Limited

Activity
30 Sep 2024
Globela Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
05 Aug 2024
A charge with Sidbi amounted to Rs. 7.35 Cr with Charge ID 100967171 was registered on 05 Aug 2024.
Activity
31 Mar 2024
Globela Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
05 Mar 2024
A charge with Axis Bank Limited of Rs. 22.06 Cr registered on 06 May 2022 with Charge ID 100568822 was modified on 05 Mar 2024.
Charges
09 Jan 2024
A charge with Axis Bank Limited of Rs. 54.47 Cr registered on 25 Mar 2022 with Charge ID 100554236 was modified on 09 Jan 2024.
Charges
19 Dec 2023
A charge with Axis Bank Limited of Rs. 42.37 Cr registered on 29 Nov 2016 with Charge ID 100065045 was modified on 19 Dec 2023.

Frequently Asked Questions about Globela Pharma Private Limited

Globela Pharma Private Limited is an active private limited company in the pharma sector based in Surat, Gujarat, India. It was incorporated on 08 February 2006 (20+ years old) and is registered under CIN U24230GJ2006PTC047699. The company has 150 employees.

Globela Pharma Private Limited reported revenue of ₹295.59 Cr for FY 2025 (up 13.00% YoY).

The current directors of Globela Pharma Private Limited are:

The primary industry of Globela Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Globela Pharma Private Limited can be reached at the registered office: Plot No. 357 – 358 Road No. 3 Gidc Sachin, Surat, Gujarat, India – 394230, or through the website globelapharma.com.

The authorised capital is ₹58 Cr, and the paid-up capital is ₹56.92 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available